Cancer Immunotherapy Based on Mutation-Specific CD4+T Cells in a Patient with Epithelial Cancer

被引:1356
作者
Tran, Eric [1 ]
Turcotte, Simon [1 ]
Gros, Alena [1 ]
Robbins, Paul F. [1 ]
Lu, Yong-Chen [1 ]
Dudley, Mark E. [1 ]
Wunderlich, John R. [1 ]
Somerville, Robert P. [1 ]
Hogan, Katherine [1 ]
Hinrichs, Christian S. [1 ]
Parkhurst, Maria R. [1 ]
Yang, James C. [1 ]
Rosenberg, Steven A. [1 ]
机构
[1] NCI, Surg Branch, NIH, Bethesda, MD 20892 USA
关键词
CD4(+) T-CELLS; METASTATIC MELANOMA; ESTABLISHED MELANOMA; TUMOR-REGRESSION; LUNG-CARCINOMA; IFN-GAMMA; IN-VIVO; LYMPHOCYTES; GENE; RESPONSES;
D O I
10.1126/science.1251102
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Limited evidence exists that humans mount a mutation-specific T cell response to epithelial cancers. We used a whole-exomic-sequencing-based approach to demonstrate that tumor-infiltrating lymphocytes (TIL) from a patient with metastatic cholangiocarcinoma contained CD4+ T helper 1 (T(H)1) cells recognizing a mutation in erbb2 interacting protein (ERBB2IP) expressed by the cancer. After adoptive transfer of TIL containing about 25% mutation-specific polyfunctional T(H)1 cells, the patient achieved a decrease in target lesions with prolonged stabilization of disease. Upon disease progression, the patient was retreated with a >95% pure population of mutation-reactive T(H)1 cells and again experienced tumor regression. These results provide evidence that a CD4+ T cell response against a mutated antigen can be harnessed to mediate regression of a metastatic epithelial cancer.
引用
收藏
页码:641 / 645
页数:5
相关论文
共 25 条
[1]   T-helper-1-cell cytokines drive cancer into senescence [J].
Braumueller, Heidi ;
Wieder, Thomas ;
Brenner, Ellen ;
Assmann, Sonja ;
Hahn, Matthias ;
Alkhaled, Mohammed ;
Schilbach, Karin ;
Essmann, Frank ;
Kneilling, Manfred ;
Griessinger, Christoph ;
Ranta, Felicia ;
Ullrich, Susanne ;
Mocikat, Ralph ;
Braungart, Kilian ;
Mehra, Tarun ;
Fehrenbacher, Birgit ;
Berdel, Julia ;
Niessner, Heike ;
Meier, Friedegund ;
van den Broek, Maries ;
Haering, Hans-Ulrich ;
Handgretinger, Rupert ;
Quintanilla-Martinez, Leticia ;
Fend, Falko ;
Pesic, Marina ;
Bauer, Juergen ;
Zender, Lars ;
Schaller, Martin ;
Schulze-Osthoff, Klaus ;
Roecken, Martin .
NATURE, 2013, 494 (7437) :361-365
[2]   Antigen Spreading Contributes to MAGE Vaccination-Induced Regression of Melanoma Metastases [J].
Corbiere, Veronique ;
Chapiro, Jacques ;
Stroobant, Vincent ;
Ma, Wenbin ;
Lurquin, Christophe ;
Lethe, Bernard ;
van Baren, Nicolas ;
Van den Eynde, Benoit J. ;
Boon, Thierry ;
Coulie, Pierre G. .
CANCER RESEARCH, 2011, 71 (04) :1253-1262
[3]   Primary antitumor immune response mediated by CD4+ T cells [J].
Corthay, A ;
Skovseth, DK ;
Lundin, KU ;
Rosjo, E ;
Omholt, H ;
Hofgaard, PO ;
Haraldsen, G ;
Bogen, B .
IMMUNITY, 2005, 22 (03) :371-383
[4]   Polyfunctional CD4+ T cells are essential for eradicating advanced B-cell lymphoma after chemotherapy [J].
Ding, Zhi-Chun ;
Huang, Lei ;
Blazar, Bruce R. ;
Yagita, Hideo ;
Mellor, Andrew L. ;
Munn, David H. ;
Zhou, Gang .
BLOOD, 2012, 120 (11) :2229-2239
[5]  
Echchakir H, 2001, CANCER RES, V61, P4078
[6]   THERAPY OF DISSEMINATED MURINE LEUKEMIA WITH CYCLOPHOSPHAMIDE AND IMMUNE LYT-1+,2- T-CELLS - TUMOR-ERADICATION DOES NOT REQUIRE PARTICIPATION OF CYTO-TOXIC T-CELLS [J].
GREENBERG, PD ;
KERN, DE ;
CHEEVER, MA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1985, 161 (05) :1122-1134
[7]  
Hogan KT, 1998, CANCER RES, V58, P5144
[8]   T cells associated with tumor regression recognize frameshifted products of the CDKN2A tumor suppressor gene locus and a mutated HLA class I gene product [J].
Huang, JP ;
El-Gamil, M ;
Dudley, ME ;
Li, YF ;
Rosenberg, SA ;
Robbins, PF .
JOURNAL OF IMMUNOLOGY, 2004, 172 (10) :6057-6064
[9]   Treatment of metastatic melanoma with autologous CD4+T cells against NY-ESO-1 [J].
Hunder, Naomi N. ;
Wallen, Herschel ;
Cao, Jianhong ;
Hendricks, Deborah W. ;
Reilly, John Z. ;
Rodmyre, Rebecca ;
Jungbluth, Achim ;
Gnjatic, Sacha ;
Thompson, John A. ;
Yee, Cassian .
NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (25) :2698-2703
[10]  
Karanikas V, 2001, CANCER RES, V61, P3718